Leuprolide IR — Medical Mutual
Prophylaxis or Treatment of Uterine Bleeding in Patients with Hematologic Malignancy or Prior to Bone Marrow/Stem Cell Transplantation (BMT/SCT)
Initial criteria
- Approve
 
Reauthorization criteria
- Approve
 
Approval duration
1 year